Develops therapies to treat cancer
Adaptimmune has raised €79M across 1 funding round from 4 investors, most recently a Series A round in Sep 2014. Based in Milton, UK; founded 2008; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-09-01 | Series A | €79M |
| New Enterprise Associates,Novo A,S,Wellington Management |
| View deal → |
